SURVIVAL-TIME MODELS FOR ANALYZING DRUG-COMBINATION TREATMENTS

被引：0
|
作者：
KUBLER, J
SCHUMACHER, M
机构：
[1] Department of Statistics, University of Dortmund, Dortmund, D-4600
[2] Institute of Medical Biometry and Informatics, University of Freiburg, Freiburg, D-7800
来源：
STATISTICS IN MEDICINE | 1990年 / 9卷 / 12期
关键词：
D O I：
10.1002/sim.4780091216
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Several relative risk models for survival time data in drug combination therapy are derived and their properties are discussed. The main intention of this paper is to clarify the differences among the models in order to help to choose the appropriate one in a given situation. The models are motivated by discussing their relation to well‐known physiological concepts. In an example of two‐drug treatment the models are compared with each other. For this chemotherapy animal survival study, dose‐risk surfaces are fitted and optimal drug combinations are estimated. Methods for checking the model assumptions are mentioned. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码：1527 / 1539
页数：13
相关论文
共 50 条
  • [31] SUCCESSIVE-DAMAGE SHOCK-MODELS PREDICTING SYSTEM SURVIVAL-TIME
    BISWAS, S
    NAIR, G
    SEHGAL, VK
    INTERNATIONAL JOURNAL OF SYSTEMS SCIENCE, 1987, 18 (05) : 831 - 836
  • [32] APPRAISAL OF A DRUG-COMBINATION FOR ANTIHYPERTENSIVE THERAPY IN AMBULATORY CARE
    VOIGT, U
    MEDIZINISCHE WELT, 1981, 32 (37): : 1368 - 1374
  • [33] ESTIMATING THE SURVIVAL-TIME OF KNEE REPLACEMENTS
    TEW, M
    WAUGH, W
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1982, 64 (05): : 579 - 582
  • [34] SURVIVAL-TIME IN CYSTINOSIS - A COLLABORATIVE STUDY
    GRETZ, N
    MANZ, F
    BARRATT, TM
    BRANDIS, M
    BREMER, HJ
    BRODEHL, J
    BROYER, M
    BULLA, M
    CALLIS, L
    CHANTLER, C
    DIEKMANN, L
    DILLON, MJ
    EGLI, F
    EHRICH, JHH
    ENDRES, W
    FANCONI, A
    FELDHOFF, C
    GEISERT, J
    GEKLE, D
    GESCHOLLBAUER, B
    GROTE, K
    GRUTTNER, R
    HAGGE, W
    HAYCOCK, GB
    HENNEMANN, H
    KLARE, B
    LEUPOLD, D
    LOHR, H
    MICHALK, D
    OTT, F
    PISTOR, K
    RAU, J
    SCHARER, K
    SCHINDERA, F
    SCHMIDT, H
    SCHULTEWISSERMANN, H
    VERRIERJONES, K
    WEBER, HP
    WILLENBOCKEL, U
    WOLF, H
    KIDNEY INTERNATIONAL, 1983, 23 (03) : 555 - 556
  • [35] DRUG-COMBINATION ADDS FUEL TO US ABORTION DEBATE
    RUTTER, TL
    BRITISH MEDICAL JOURNAL, 1995, 311 (7007): : 705 - 705
  • [36] ROBUST PROCEDURES FOR DRUG-COMBINATION PROBLEMS WITH QUANTAL RESPONSES
    VIDMAR, TJ
    MCKEAN, JW
    HETTMANSPERGER, TP
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 1992, 41 (02) : 299 - 315
  • [37] AN IMPROVED VASOACTIVE DRUG-COMBINATION FOR A PHARMACOLOGICAL ERECTION PROGRAM
    BENNETT, AH
    CARPENTER, AJ
    BARADA, JH
    JOURNAL OF UROLOGY, 1991, 146 (06): : 1564 - 1565
  • [38] THE GP AND DRUG-COMBINATION FOR PAINS IN CANCER .10.
    BURUCOA, B
    SUCHAUD, JP
    GAZETTE MEDICALE, 1989, 96 (21): : 55 - &
  • [39] PROMISING DRUG-COMBINATION FOR SICKLE-CELL ANEMIA
    MERZ, B
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (21): : 3069 - 3069
  • [40] THROMBOCYTE SURVIVAL-TIME IN MYELOPROLIFERATIVE DISEASES
    LINKESCH, W
    SINZINGER, H
    SILBERBAUER, K
    ACTA MEDICA AUSTRIACA, 1981, 8 : 194 - 195
12345